>NEWS
NEWS2019-04-16T20:08:19+00:00

SWIFT NEWS

Our Newest Publications

Targeted sequencing panel IDs Lynch syndrome in women with/at risk for endometrial cancer A targeted next-generation sequencing panel rapidly identifies both germline and somatic Lynch syndrome pathogenic mutations in women with – or at risk for – endometrial cancer, according to findings [...]

February 16th, 2019|
  • Francesco Criscuolo

Swift in Action

Francesco Criscuolo speaking towards the use of molecular identifiers and targeted NGS to enable variant detection below 1% allele frequencies in cfDNA. Presented at AMP 2018.

January 16th, 2019|

Swift Biosciences Launches Swift Amplicon 16S+ITS Panel, Answering Long-Awaited Need for Comprehensive, Rapid Coverage of Metagenomic Sequences by NGS

(ANN ARBOR, Mich. – January 16, 2019) Swift Biosciences today announced the launch of its Swift Amplicon 16S+ITS Panel, facilitating routine NGS analysis of complex microbial samples (e.g. bacteria, archaea, fungi) using a single, multiplexed primer pool targeting the 16S rRNA gene (all variable [...]

January 16th, 2019|

Swift Biosciences Announces ISO 13485:2016 Certification

Ann Arbor, Michigan (January 7, 2019) - Swift Biosciences, Inc. a manufacturer of precision next-generation sequencing (NGS) solutions, announces it has received International Organization Standardization (ISO) 13485:2016 certification for design, development, production, and distribution of molecular biology and related reagents in both standard and [...]

January 7th, 2019|

Swift Biosciences Launches Normalase™, Radically Streamlining and Improving NGS Library Normalization

(ANN ARBOR, Mich. – November 28, 2018) Swift Biosciences today announced the availability of its eagerly anticipated Normalase™ Kit, a revolutionary enzymatic library normalization product that streamlines the cumbersome steps following next-generation sequencing (NGS) library preparation. Compared to conventional normalization, Swift Normalase saves cost [...]

November 28th, 2018|

Swift Biosciences Launches Swift Amplicon HS Panels, Enabling Confident Targeted Detection of Low Frequency Variants from Liquid Biopsy Sequencing

(ANN ARBOR, Mich. - Aug. 28, 2018 ) Swift Biosciences today announced early access availability of its Swift Amplicon HS Panels, a new, high-sensitivity targeted amplicon library preparation kit for next-generation sequencing (NGS) of liquid biopsy samples, including cell-free DNA (cfDNA). This addition to Swift's targeted [...]

August 28th, 2018|